IT IS SEPTEMBER 4, 1991. Researchers from academic centers across the country are gathered at the Hunt Valley Conference Center in Maryland. To an observer, the event looks like any other professional conference. However, it is anything but ordinary. It is the start of a new frontier in health research.
The scientists hail from different fields of study, yet all are devoted to studying women’s health. Invited by the newly established Office of Research on Women’s Health within the National Institutes of Health (NIH), they are tasked with setting a research agenda to address the troubling gaps in scientific information on the health of women. It is a pivotal moment in the history of science and medicine.
Over the previous 40 years, the United States had made a dramatic investment in scientific research. The NIH had grown to become the world’s greatest single funder of biomedical research and set the standard for the direction and design of future research. There was, however, a glaring omission: NIH policies did not require the inclusion of women in clinical studies.
At the time, researchers believed that women’s hormone cycles could complicate study results. It was also thought that women needed to be protected from any possible risk involved in scientific inquiry—despite safeguards dictated by protocols. As a result, women were generally excluded as research participants, and that’s why the Hunt Valley gathering was so important. These scientists were poised to change the standard of research, leading to federal legislation in 1993 that required women to be included in all future clinical research funded by the NIH.